BCMALL
0187
PERMAJU-PA
7080PA
EAH
0154
KGROUP
0036
NOVAMSC-PA
0026PA
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 6,480.95%2.76M | -220.92%-1.13M | -124.53%-1.03M | 680.80%2.03M | -86.20%-3.13M | -97.27%42K | 107.76%937K | 734.95%4.18M | 28.78%-349K | -122.61%-1.68M |
Net profit before non-cash adjustment | -43.06%-4.23M | -675.32%-4.9M | -3.56%-2.62M | -2.99%-13.88M | -84.20%-7.76M | 33.45%-2.95M | 88.20%-632K | -573.22%-2.53M | -85.06%-13.47M | -336.00%-4.22M |
Total adjustment of non-cash items | -110.49%-47K | 630.02%2.83M | -109.65%-44K | 170.68%5.6M | 286.32%5.23M | -20.28%448K | -117.05%-533K | -61.65%456K | -81.80%2.07M | -127.09%-2.81M |
-Depreciation and amortization | -44.51%192K | 3.81%218K | -16.33%205K | -40.05%654K | -177.78%-147K | 18.09%346K | -32.26%210K | -18.06%245K | -23.33%1.09M | -50.65%189K |
-Reversal of impairment losses recognized in profit and loss | 2,900.00%28K | ---- | ---- | 496.02%5.54M | 493.98%5.52M | ---1K | ---- | ---- | -86.55%930K | --930K |
-Disposal profit | ---328K | --0 | ---326K | 75.96%-1.09M | 95.23%-197K | --0 | ---896K | --0 | -12.80%-4.55M | ---4.13M |
-Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.84M | --0 |
-Other non-cash items | -40.78%61K | -44.36%74K | -63.51%77K | -81.90%499K | -74.63%52K | -84.39%103K | -86.73%133K | -76.29%211K | -60.99%2.76M | -97.11%205K |
Changes in working capital | 176.18%7.04M | -55.19%942K | -73.82%1.64M | -6.82%10.3M | -111.19%-598K | -52.95%2.55M | -21.51%2.1M | 362.45%6.25M | 341.16%11.06M | 213.30%5.34M |
-Change in receivables | 1,335.92%2.55M | 22.90%-3.4M | -113.76%-1.46M | -82.93%2.64M | -127.55%-3.37M | -104.76%-206K | ---4.41M | --10.62M | 212.31%15.46M | --12.22M |
-Change in inventory | 140.11%1.74M | -26.93%2.41M | 163.51%1.22M | 183.80%2.7M | 118.50%595K | --723K | --3.3M | ---1.92M | -126.26%-3.22M | ---3.22M |
-Change in payables | 35.65%2.76M | -39.90%1.93M | 176.62%1.88M | -45.20%1.94M | -179.91%-851K | 86.84%2.03M | --3.21M | ---2.45M | -60.88%3.54M | --1.07M |
-Changes in other current assets | ---- | ---- | ---- | 163.97%3.03M | ---- | ---- | ---- | ---- | 60.98%-4.73M | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 37.04%-85K | 40.85%-97K | 59.83%-96K | 79.87%-633K | 63.32%-95K | 82.51%-135K | 84.81%-164K | 76.89%-239K | 65.30%-3.15M | 95.60%-259K |
Interest received (cash flow from operating activities) | -25.00%24K | -25.81%23K | -32.14%19K | -62.42%121K | 350.00%30K | -71.43%32K | -69.31%31K | -76.86%28K | -49.37%322K | -104.24%-12K |
Tax refund paid | -107.23%-6K | 93.60%-11K | 68.16%-64K | -12.01%-457K | 15.66%-167K | 138.25%83K | -118.12%-172K | 78.66%-201K | -684.62%-408K | -292.23%-198K |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | 12,159.09%2.7M | -292.72%-1.22M | -130.96%-1.17M | 129.55%1.06M | -56.37%-3.36M | -96.68%22K | 50.12%632K | 249.86%3.77M | 60.08%-3.58M | -210.77%-2.15M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 93.33%-6K | -100.28%-1K | 544.92%525K | -46.73%228K | 2.74%75K | -121.18%-90K | 646.97%361K | -2,850.00%-118K | 173.92%428K | -82.41%73K |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -904.45%-4.96M | ---- |
Net investment property transactions | --438K | ---- | ---- | 138.67%1.07M | -27.33%327K | --0 | ---- | ---- | -70.59%450K | --450K |
Net investment product transactions | --0 | --0 | --0 | ---- | ---- | 99.90%-8K | -101.58%-132K | -2,733.33%-85K | ---- | ---- |
Investing cash flow | 179.41%432K | 99.64%-1K | 358.62%525K | 131.88%1.3M | 152.35%2.32M | 93.12%-544K | -103.33%-275K | -2,800.00%-203K | -993.65%-4.08M | -329.05%-4.44M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 80.96%-364K | 87.31%-364K | 88.03%-364K | 65.94%-8.31M | 69.51%-490K | 65.08%-1.91M | 80.55%-2.87M | -18.51%-3.04M | -791.27%-24.4M | 33.01%-1.61M |
Net common stock issuance | --0 | --1.35M | --1.99M | --0 | ---250K | --250K | --0 | --0 | -76.32%6.69M | --0 |
Increase or decrease of lease financing | 42.18%-85K | -3.66%-85K | -35.29%-69K | 23.85%-265K | 109.38%15K | -110.00%-147K | -54.72%-82K | 21.54%-51K | 41.02%-348K | 57.56%-160K |
Net other fund-raising expenses | ---1.39M | ---558K | -300.00%-8K | -101.27%-235K | -101.26%-233K | --0 | --0 | -100.16%-2K | 889.14%18.53M | 890.87%18.54M |
Financing cash flow | -1.71%-1.84M | 111.62%343K | 150.13%1.55M | -1,986.94%-8.81M | -105.71%-958K | 67.38%-1.81M | 74.04%-2.95M | -608.88%-3.09M | -98.38%467K | 427.56%16.77M |
Net cash flow | ||||||||||
Beginning cash position | -68.31%1.99M | -67.70%2.87M | -76.72%1.96M | -46.11%8.41M | -67.66%3.95M | -43.27%6.29M | -34.53%8.88M | -46.34%8.41M | 435.85%15.61M | -60.81%12.23M |
Current changes in cash | 155.30%1.29M | 66.23%-876K | 94.03%910K | 10.35%-6.45M | -119.60%-2M | 81.77%-2.33M | 3.28%-2.59M | 124.53%469K | -135.42%-7.2M | 920.47%10.18M |
End cash Position | -17.02%3.28M | -68.31%1.99M | -67.70%2.87M | -76.72%1.96M | -76.72%1.96M | -67.66%3.95M | -43.27%6.29M | -34.53%8.88M | -46.34%8.41M | -46.34%8.41M |
Free cash flow | 584.86%2.69M | -50.12%-1.22M | -132.07%-1.17M | 119.18%732K | 32.42%-1.55M | -183.84%-555K | -328.73%-812K | 243.57%3.65M | 60.32%-3.82M | -200.26%-2.29M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.